Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors

Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors

US Patent 6169091 · Granted Jan 2, 2001

Estimated economic value: $26,064,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical compounds2025
Pharmaceutical compounds2025
Pharmaceutical compounds2023
Cyclic triazo and diazo sodium channel blockers2018
Tetrazole compounds as calcium channel blockers2017
IP receptor agonist heterocyclic compounds2017
Cyclic triazo and diazo sodium channel blockers2016
Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors2015
Salts of 7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic ac2015
Substituted pyrido[2,3-B]pyrazines as IP receptor agonists2015
Substituted pyrido[2,3-B]pyrazines as IP receptor agonists2015
Tetrazole compounds as calcium channel blockers2015